Growth Metrics

Wave Life Sciences (WVE) Free Cash Flow Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 60.84%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 88.70%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -15.72%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 66.37%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 3.98%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 137.65%
10 Wave Life Sciences 1.32 Bn 772.50 Mn - 5.08%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.08%
Dec 31, 2025 22.77%
Sep 30, 2025 4.15%
Jun 30, 2025 -68.31%
Mar 31, 2025 -86.72%
Dec 31, 2024 -30.18%
Sep 30, 2024 -35.22%
Jun 30, 2024 26.28%
Mar 31, 2024 -139.81%
Dec 31, 2023 0.15%
Sep 30, 2023 -32.76%
Jun 30, 2023 -27.34%
Mar 31, 2023 312.15%
Dec 31, 2022 -377.36%
Sep 30, 2022 7.70%
Jun 30, 2022 -200.97%
Mar 31, 2022 9.90%
Dec 31, 2021 77.96%
Sep 30, 2021 -39.75%
Jun 30, 2021 74.56%
Mar 31, 2021 -65.80%
Dec 31, 2020 48.92%
Sep 30, 2020 54.16%
Jun 30, 2020 -10.87%
Mar 31, 2020 47.28%
Dec 31, 2019 -72.49%
Sep 30, 2019 -36.26%
Jun 30, 2019 -149.70%
Mar 31, 2019 -51.50%
Dec 31, 2018 9.79%
Sep 30, 2018 -107.31%
Jun 30, 2018 364.01%
Mar 31, 2018 -64.71%
Dec 31, 2017 -132.24%
Sep 30, 2017 -31.73%
Jun 30, 2017 -2,563.36%
Mar 31, 2017 -178.57%
Dec 31, 2016 -126.75%
Sep 30, 2016 -253.41%
Jun 30, 2016 43.64%
Mar 31, 2016 -347.49%
Dec 31, 2015 -1,034.92%